Teacher Retirement System of Texas increased its stake in shares of agilon health, inc. (NYSE:AGL – Get Rating) by 10.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,312 shares of the company's stock after buying an additional 3,426 shares during the period. Teacher Retirement System of Texas' holdings in agilon health were worth $827,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Van ECK Associates Corp purchased a new stake in agilon health during the third quarter worth about $45,000. Lazard Asset Management LLC acquired a new position in agilon health during the first quarter worth about $69,000. Vigilant Capital Management LLC acquired a new position in agilon health during the third quarter worth about $102,000. Macquarie Group Ltd. acquired a new position in agilon health during the second quarter worth about $134,000. Finally, SG Americas Securities LLC acquired a new position in agilon health during the second quarter worth about $173,000.

agilon health Stock Performance

NYSE:AGL opened at $22.05 on Friday. The firm has a 50 day simple moving average of $18.19 and a 200-day simple moving average of $20.65. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.48 and a quick ratio of 2.48. The firm has a market cap of $9.08 billion, a PE ratio of -84.81 and a beta of 1.09. agilon health, inc. has a 1-year low of $14.82 and a 1-year high of $28.36.

Insider Buying and Selling

In related news, insider Benjamin Kornitzer sold 5,398 shares of the company's stock in a transaction that occurred on Monday, December 5th. The shares were sold at an average price of $17.80, for a total transaction of $96,084.40. Following the completion of the transaction, the insider now owns 10,426 shares of the company's stock, valued at $185,582.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other agilon health news, insider Benjamin Shaker sold 20,723 shares of the business's stock in a transaction that occurred on Wednesday, January 18th. The shares were sold at an average price of $19.78, for a total transaction of $409,900.94. Following the completion of the sale, the insider now directly owns 25,625 shares in the company, valued at $506,862.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Benjamin Kornitzer sold 5,398 shares of the business's stock in a transaction that occurred on Monday, December 5th. The stock was sold at an average price of $17.80, for a total transaction of $96,084.40. Following the sale, the insider now owns 10,426 shares of the company's stock, valued at $185,582.80. The disclosure for this sale can be found here. Over the last quarter, insiders sold 39,613 shares of company stock valued at $746,114. Insiders own 3.30% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. SVB Leerink cut their target price on shares of agilon health from $33.00 to $30.00 and set an "outperform" rating for the company in a research report on Friday, November 4th. Wells Fargo & Company cut their target price on shares of agilon health from $28.00 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, November 15th. The Goldman Sachs Group cut their target price on shares of agilon health from $38.00 to $34.00 and set a "buy" rating for the company in a research report on Tuesday, November 15th. Finally, Stifel Nicolaus initiated coverage on shares of agilon health in a research report on Thursday, December 8th. They set a "buy" rating and a $23.00 target price for the company. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, agilon health presently has a consensus rating of "Moderate Buy" and an average price target of $28.38.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Further Reading

• Get a free copy of the StockNews.com research report on agilon health (AGL)
• Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
• Zimmer Biomet Beats on Earnings, Growth May be Priced In
• AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
• Ford Stock Going Forward After Big Earnings Flop
• Insiders And Institutions Buy Wolverine Worldwide

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.